Steven Bulwa

Tech, biotech, small-cap, growth at reasonable price
Steven Bulwa
Tech, biotech, small-cap, growth at reasonable price
Contributor since: 2010
Get ready for today's market
Theodore Cohen, Contributor
long only, biotech, healthcare, mid-cap
Journalist, Commodities, Developed International Markets
Michael Shulman, Contributor
research analyst, long/short equity, dividend investing, ETF investing
Steven Bulwa, Contributor
tech, biotech, small-cap, growth at reasonable price
optionMONSTER, Contributor
Newsletter author, ETFs, Options
Philip Davis, Contributor
Stock and Options Newsletter, Teaches Hedging Strategies, Smart Portfolio Management
The GeoTeam, Contributor
long/short equity, event-driven, research analyst, activist investor
long/short equity, research analyst, tech, internet
John Petersen, Contributor
long-term horizon, nano-cap, micro-cap, alternative energy
Jason Schwarz, Contributor
long/short equity, special situations, momentum, research analyst
Satwaves, Contributor
Full-time Investor, Bonds, Dividend stock ideas & income
Robert Freedland, Contributor
long only, dividend investing, energy, tech
Dr. Kris, Contributor
research analyst, portfolio strategy, long/short equity, special situations
MagicDiligence, Contributor
growth at reasonable price, long only, value, proprietary formula investing
contrarian, growth at reasonable price, management change, cannabis stocks
Newsletter author, ETFs, Options
Keith Woolcock, Contributor
Newsletter author, Developed International Markets, ETFs
Gary Tanashian, Contributor
newsletter provider, long/short equity, macro, gold
growth, long/short equity, growth at reasonable price
Jim Van Meerten, Contributor
long only, momentum, investment advisor, portfolio strategy
Michael Kudrna, Contributor
long/short equity, deep value, momentum, contrarian
Joshua Hayes, Contributor
Independent trader, Mutual funds, Retirement savings
Everyday Finance, Contributor
ETF investing, independent research, tech
growth at reasonable price, activist investor, value